Not yet recruiting
Metastatic malignant melanoma+2
Not yet recruitingMethoxsalen (ECP) versus drug combination for steroid‑refractory immune‑related colitis or hepatitis in metastatic melanoma on checkpoint therapy
Registered drugNo placebo
Methoxsalen (ECP) versus drug combination for steroid‑refractory immune‑related colitis or hepatitis in metastatic melanoma on checkpoint therapy
Registered drugNo placebo
- Disease:Metastatic malignant melanomaColitis+1
- Substances:AzathioprineInfliximab+3
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Azathioprine
